Saptak Chem Reports FY26 Net Loss of ₹30.21 Lakh

Saptak Chem & Business has announced its standalone audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 14, 2026, at the company's registered office in Ahmedabad.

Financial Performance

The company reported a net loss of ₹30.21 lakh for the financial year ended March 31, 2026, widening from a net loss of ₹8.62 lakh in the previous year. For the quarter ended March 31, 2026, the net loss stood at ₹12.49 lakh.

Revenue from operations was nil at ₹0.00 lakh for both the quarter and the fiscal year. Total revenue, which includes other income, was ₹0.26 lakh for FY26, up from ₹0.06 lakh in the previous year. Other income for the quarter was ₹0.00 lakh.

Total expenses for the year increased to ₹30.47 lakh from ₹8.68 lakh in the prior year. This rise was primarily driven by employee benefits expense, which totaled ₹5.29 lakh, and other expenses amounting to ₹25.18 lakh.

Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Net Profit / (Loss)	(30.21)	(8.62)
Total Revenue	0.26	0.06
Total Expenses	30.47	8.68
Earnings Per Share (Basic)	(2.81)	(0.08)

Operational and Balance Sheet Details

The company reported zero outstanding loans or debt securities as of March 31, 2026. Cash and cash equivalents improved significantly to ₹25.32 lakh as of March 31, 2026, compared to ₹0.82 lakh in the previous year. Total current assets were reported at ₹114.80 lakh.

The statutory auditors, M/s. P H Shah & Co, issued an unmodified opinion on the audited financial results. The financial statements were reviewed by the Audit Committee and are in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Saptak Chem & Business Limited has announced a significant equity acquisition through preferential allotment, with Jayshree Jain emerging as a substantial shareholder. The transaction, disclosed under SEBI's substantial acquisition regulations on April 8, 2026, marks a notable expansion in the company's equity base and investor participation.

Acquisition Details

The acquisition involves Jayshree Jain, who does not belong to the promoter or promoter group, acquiring shares through preferential allotment. The transaction was completed on April 6, 2026, with formal disclosure made under Regulation 29(1) of SEBI (SAST) Regulations, 2011.

Parameter:	Details
Acquirer:	Jayshree Jain
Shares Acquired:	5,00,000
Acquisition Mode:	Preferential Allotment
Transaction Date:	April 6, 2026
Promoter Status:	Non-promoter entity

Shareholding Impact

The acquisition represents a substantial stake in the company, with Jayshree Jain securing a significant voting position. Prior to this transaction, the acquirer held no shares in the company.

Shareholding Metric:	Before Acquisition	After Acquisition
Shares Held:	-	5,00,000
Voting Capital %:	-	16.27%
Diluted Capital %:	-	9.86%

Capital Structure Changes

The preferential allotment has resulted in a substantial expansion of the company's equity base. The transaction involves convertible warrants, with each warrant convertible into one fully paid equity share of ₹10.00 each.

Capital Parameter:	Before Transaction	After Transaction
Equity Share Capital:	₹1,07,32,270	₹3,07,32,270
Number of Equity Shares:	10,73,227	30,73,227
Total Diluted Share Capital:	-	50,73,227

Regulatory Compliance

The disclosure has been made in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company's shares are listed on BSE Limited, ensuring transparency and regulatory oversight of the transaction.

The convertible nature of the securities provides flexibility for future equity conversion, with the warrants carrying specific terms for conversion into fully paid equity shares. This structure allows for potential future expansion of the acquirer's stake based on the conversion timeline and terms specified in the warrant agreement.